LENZ Therapeutics, Inc.
LENZ
Amendment
Ownership
7.50%
Total Shares
2,101,199
Issuer CIK
1815776
CUSIP
52635N103
Event Date
Jun 9, 2025
Accepted
Jun 12, 2025, 04:49 PM
SEC EDGARView Original Filing
Reporting Persons (9)
Joint Filing
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P. | Partnership | 7.50% | 2,101,199 | 2,101,199 | 0 |
| Versant Ventures VI GP, L.P. | Partnership | 7.50% | 2,101,199 | 0 | 2,101,199 |
| Versant Ventures VI GP-GP, LLC | Other | 7.50% | 2,101,199 | 0 | 2,101,199 |
| Versant Ventures VII GP-GP, LLC | Other | 4.70% | 1,319,323 | 0 | 1,319,323 |
| Versant Venture Capital VII, L.P. | Partnership | 4.70% | 1,319,323 | 1,319,323 | 0 |
| Versant Ventures VII GP, L.P. | Partnership | 4.70% | 1,319,323 | 0 | 1,319,323 |
| Versant Vantage II, L.P. | Partnership | 3.00% | 842,162 | 842,162 | 0 |
| Versant Vantage II GP, L.P. | Partnership | 3.00% | 842,162 | 0 | 842,162 |
| Versant Vantage II GP-GP, LLC | Other | 3.00% | 842,162 | 0 | 842,162 |
Disclosure Items (2)
Security Title
Common Stock, par value $0.00001 per share
Issuer Name
LENZ Therapeutics, Inc.
Issuer Address
201 Lomas Santa Fe Dr., Solana Beach, CA, 92075
Percentage of Class
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
Number of Shares
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
Transactions
On June 10, 2025, Versant VII sold 350,000 shares of Common Stock at a price per share of $29.00 for aggregate proceeds of approximately $10,150,000.00